SCHEMBL9706316

SCHEMBL9706316

CCOC(=O)CCCCN=C=S

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.48
NAAA Q02083 1/20 0.47
KEAP1 Q14145 3/20 0.44
NFE2L2 Q16236 3/20 0.44
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43
PRSS3 P35030 1/20 0.43
MIF P14174 3/20 0.42
ALDH1A1 P00352 2/20 0.42
PTGS2 P35354 2/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
BACH1 O14867 1/20 0.42
MAFK O60675 1/20 0.42
EGFR P00533 1/20 0.42
CYP3A4 P08684 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3083780 0.95 CYP1A2 (0.50) CYP1A2NAAAKEAP1NFE2L2MIF
SCHEMBL1457047 0.87 CYP1A2 (0.44) CYP1A2NAAAKEAP1NFE2L2ALDH1A1
SCHEMBL1201485 0.82 CYP1A2 (0.48) CYP1A2PRSS1PRSS2PRSS3ALDH1A1
SCHEMBL11455382 0.82 CYP1A2 (0.48) CYP1A2PRSS1PRSS2PRSS3ALDH1A1
SCHEMBL11260906 0.82 CYP1A2 (0.48) CYP1A2PRSS1PRSS2PRSS3ALDH1A1
SCHEMBL17519951 0.81 TSHR (0.52) NAAAKEAP1NFE2L2MIFALDH1A1
SCHEMBL11177812 0.80 TSHR (0.50) NAAAKEAP1NFE2L2MIFALDH1A1
SCHEMBL13123489 0.80 TSHR (0.50) NAAAKEAP1NFE2L2MIFALDH1A1
SCHEMBL2824773 0.80 TSHR (0.50) NAAAKEAP1NFE2L2MIFALDH1A1
Bromide SCHEMBL18889105 0.79 CYP1A2 (0.36) CYP1A2NAAAKEAP1NFE2L2MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992013530-A1 TRANSGLUTAMINASE ENZYME INHIBITORS MEDICIS CORPORATION (US) 1992-08-20 WO disclosed